203 related articles for article (PubMed ID: 29873112)
1. Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging.
Wennberg AMV; Hagen CE; Edwards K; Roberts RO; Machulda MM; Knopman DS; Petersen RC; Mielke MM
Int J Geriatr Psychiatry; 2018 Aug; 33(8):1114-1120. PubMed ID: 29873112
[TBL] [Abstract][Full Text] [Related]
2. Long-term metformin usage and cognitive function among older adults with diabetes.
Ng TP; Feng L; Yap KB; Lee TS; Tan CH; Winblad B
J Alzheimers Dis; 2014; 41(1):61-8. PubMed ID: 24577463
[TBL] [Abstract][Full Text] [Related]
3. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
[TBL] [Abstract][Full Text] [Related]
4. Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging.
Alhurani RE; Vassilaki M; Aakre JA; Mielke MM; Kremers WK; Machulda MM; Geda YE; Knopman DS; Petersen RC; Roberts RO
JAMA Neurol; 2016 Apr; 73(4):439-46. PubMed ID: 26831542
[TBL] [Abstract][Full Text] [Related]
5. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
[TBL] [Abstract][Full Text] [Related]
6. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study.
Samaras K; Makkar S; Crawford JD; Kochan NA; Wen W; Draper B; Trollor JN; Brodaty H; Sachdev PS
Diabetes Care; 2020 Nov; 43(11):2691-2701. PubMed ID: 32967921
[TBL] [Abstract][Full Text] [Related]
7. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
8. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
Mary A; Hartemann A; Liabeuf S; Aubert CE; Kemel S; Salem JE; Cluzel P; Lenglet A; Massy ZA; Lalau JD; Mentaverri R; Bourron O; Kamel S
Cardiovasc Diabetol; 2017 Feb; 16(1):24. PubMed ID: 28202017
[TBL] [Abstract][Full Text] [Related]
9. Association between Metformin Use and Coronary Artery Calcification in Type 2 Diabetic Patients.
Lu Y; Wang Y; Weng T; Chen Z; Sun X; Wei J; Cai Z; Xiang M
J Diabetes Res; 2019; 2019():9484717. PubMed ID: 31192264
[TBL] [Abstract][Full Text] [Related]
10. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
Losada E; Soldevila B; Ali MS; Martínez-Laguna D; Nogués X; Puig-Domingo M; Díez-Pérez A; Mauricio D; Prieto-Alhambra D
Osteoporos Int; 2018 Sep; 29(9):2079-2086. PubMed ID: 29860664
[TBL] [Abstract][Full Text] [Related]
11. The Cross-sectional and Longitudinal Associations Between IL-6, IL-10, and TNFα and Cognitive Outcomes in the Mayo Clinic Study of Aging.
Wennberg AMV; Hagen CE; Machulda MM; Knopman DS; Petersen RC; Mielke MM
J Gerontol A Biol Sci Med Sci; 2019 Jul; 74(8):1289-1295. PubMed ID: 30256904
[TBL] [Abstract][Full Text] [Related]
12. Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records.
Doran W; Tunnicliffe L; Muzambi R; Rentsch CT; Bhaskaran K; Smeeth L; Brayne C; Williams DM; Chaturvedi N; Eastwood SV; Dunachie SJ; Mathur R; Warren-Gash C
BMJ Open Diabetes Res Care; 2024 Jan; 12(1):. PubMed ID: 38272537
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.
Pudumjee SB; Lundt ES; Albertson SM; Machulda MM; Kremers WK; Jack CR; Knopman DS; Petersen RC; Mielke MM; Stricker NH
J Alzheimers Dis; 2021; 83(2):861-877. PubMed ID: 34366338
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
16. The characteristic of cognitive function in Type 2 diabetes mellitus.
Gao Y; Xiao Y; Miao R; Zhao J; Zhang W; Huang G; Ma F
Diabetes Res Clin Pract; 2015 Aug; 109(2):299-305. PubMed ID: 26004430
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
Koro CE; Bowlin SJ; Weiss SR
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
[TBL] [Abstract][Full Text] [Related]
18. Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women.
Winkler A; Dlugaj M; Weimar C; Jöckel KH; Erbel R; Dragano N; Moebus S
J Alzheimers Dis; 2014; 42(4):1269-77. PubMed ID: 25024326
[TBL] [Abstract][Full Text] [Related]
19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
20. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
